Manganese superoxide dismutase Ile58Thr, catalase C-262T and myeloperoxidase G-463A gene polymorphisms in patients with prostate cancer: Relation to advanced and metastatic disease

BJU International

Volumn 112, Issue 4, 2013, Pages

  Tefik, Tzevat ^a   Kucukgergin, Canan ^a   Sanli, Oner ^a   Oktar, Tayfun ^a   Seckin, Sule ^a   Ozsoy, Cavit ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

catalase; manganese superoxide dismutase; myeloperoxidase; prostate cancer

Indexed keywords

CATALASE; MANGANESE SUPEROXIDE DISMUTASE; MYELOPEROXIDASE; PROSTATE SPECIFIC ANTIGEN;

ADULT; ADVANCED CANCER; ARTICLE; BONE METASTASIS; CANCER RISK; CANCER STAGING; CATALASE GENE; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANGANESE SUPEROXIDE DISMUTASE GENE; MYELOPEROXIDASE GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TURKEY (REPUBLIC);

CATALASE; MANGANESE SUPEROXIDE DISMUTASE; MYELOPEROXIDASE; PROSTATE CANCER;

CATALASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PEROXIDASE; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; SUPEROXIDE DISMUTASE;

EID: 84880783612     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12176     Document Type: Article

References (49)

1. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29
2. Ho SM, Lee MT, Lam HM, Leung YK,. Estrogens and prostate cancer: etiology, mediators, prevention, and management. Endocrinol Metab Clin North Am 2011; 40: 591-614
3. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M,. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006; 160: 1-40
4. Cooke MS, Evans MD, Dizdaroglu M, Lunec J,. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 2003; 17: 1195-1214
5. Dargel R,. Lipid peroxidation-a common pathogenetic mechanism?. Exp Toxicol Pathol 1992; 44: 169-181
6. Morel Y, Barouki R,. Repression of gene expression by oxidative stress. Biochem J 1999; 342: 481-496
7. Al-Gadani Y, El-Ansary A, Attas O, Al-Ayadhi L,. Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children. Clin Biochem 2009; 42: 1032-1040
8. Zhong W, Oberley LW, Oberley TD, St Clair DK,. Suppression of the malignant phenotype of human glioma cells by overexpression of manganese superoxide dismutase. Oncogene 1997; 14: 481-490
9. Wang V, Chen S-Y, Chuang TC, Shan D-E, Soong BW, Kao MC,. Val-9Ala and Ile+58Thr polymorphism of MnSOD in Parkinson's disease. Clin Biochem 2010; 43: 979-982
10. Zhang HJ, Yan T, Oberley TD, Oberley LW,. Comparison of effects of two polymorphic variants of manganese superoxide dismutase on human breast MCF-7 cancer cell phenotype. Cancer Res 1999; 59: 6276-6283
11. Ambrosone CB, Ahn J, Singh KK, et al. Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer. Cancer Res 2005; 65: 1105-1111
12. Battisti V, Maders LDK, Bagatini MD, et al. Oxidative stress and antioxidant status in prostate cancer patients: relation to Gleason score, treatment and bone metastasis. Biomed Pharmacother 2011; 65: 516-524
13. Ahn J, Nowell S, McCann SE, et al. Associations between catalase phenotype and genotype: modification by epidemiologic factors. Cancer Epidemiol Biomarkers Prev 2006; 15: 1217-1222
14. Choi JY, Neuhouser ML, Barnett M, et al. Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers. Cancer Epidemiol Biomarkers Prev 2007; 16: 1115-1120
15. Ahn J, Gammon MD, Santella RM, et al. Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use. Am J Epidemiol 2005; 162: 943-952
16. Hung RJ, Boffetta P, Brennan P, et al. Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis 2004; 25: 973-978
17. Stubbins MJ, Wolf CR,. Chapter 21. Additional polymorphisms and cancer. IARC Sci Publ 1999; 148: 271-302
18. Chu H, Wang M, Wang M, et al. The MPO -463G>A polymorphism and cancer risk: a meta-analysis based on 43 case-control studies. Mutagenesis 2010; 25: 389-395
19. Piedrafita FJ, Molander RB, Vansant G, Orlova EA, Pfahl M, Reynolds WF,. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J Biol Chem 1996; 271: 14412-14420
20. Feyler A, Voho A, Bouchardy C, et al. Point: myeloperoxidase -463G - > a polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2002; 11: 1550-1554
21. Ahn J, Ambrosone CB, Kanetsky PA, et al. Polymorphisms in genes related to oxidative stress (CAT, MnSOD, MPO, and eNOS) and acute toxicities from radiation therapy following lumpectomy for breast cancer. Clin Cancer Res 2006; 12: 7063-7070
22. Buch SC, Nazar-Stewart V, Weissfeld JL, Romkes M,. Case-control study of oral and oropharyngeal cancer in whites and genetic variation in eight metabolic enzymes. Head Neck 2008; 30: 1139-1147
23. Choi JY, Neuhouser ML, Barnett MJ, et al. Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort. Carcinogenesis 2008; 29: 964-970
24. Cai Q, Shu X-O, Wen W, et al. Genetic polymorphism in the manganese superoxide dismutase gene, antioxidant intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Breast Cancer Res 2004; 6: R647-655
25. D'souza A, Kurien BT, Rodgers R, et al. Detection of catalase as a major protein target of the lipid peroxidation product 4-HNE and the lack of its genetic association as a risk factor in SLE. BMC Med Genet 2008; 9: 62
26. Zhang J, Zhu F-Y, Pu Y-P, et al. Analysis of multiple single nucleotide polymorphisms (SNPs) of myeloperoxidase (MPO) to screen for genetic markers associated with acute leukemia in Chinese Han population. J Toxicol Environ Health A 2007; 70: 901-907
27. Khandrika L, Kumar B, Koul S, Maroni P, Koul HK,. Oxidative stress in prostate cancer. Cancer Lett 2009; 282: 125-136
28. Fleshner NE, Klotz LH,. Diet, androgens, oxidative stress and prostate cancer susceptibility. Cancer Metastasis Rev 1999; 17: 325-330
29. Kim A, Murphy MP, Oberley TD,. Mitochondrial redox state regulates transcription of the nuclear-encoded mitochondrial protein manganese superoxide dismutase: a proposed adaptive response to mitochondrial redox imbalance. Free Radic Biol Med 2005; 38: 644-654
30. Mao C, Qiu L-X, Zhan P, et al. MnSOD Val16Ala polymorphism and prostate cancer susceptibility: a meta-analysis involving 8,962 subjects. J Cancer Res Clin Oncol 2010; 136: 975-979
31. Liwei L, Chunyu L, Ruifa H,. Association between manganese superoxide dismutase gene polymorphism and risk of prostate cancer: a meta-analysis. Urology 2009; 74: 884-888
32. Tomblyn M, Kasarskis EJ, Xu Y, St Clair DK,. Distribution of MnSOD polymorphisms in sporadic ALS patients. J Mol Neurosci 1998; 10: 65-66
33. Gałecki P, Smigielski J, Florkowski A, Bobińska K, Pietras T, Szemraj J,. Analysis of two polymorphisms of the manganese superoxide dismutase gene (Ile-58Thr and Ala-9Val) in patients with recurrent depressive disorder. Psychiatry Res 2010; 179: 43-46
34. Kucukgergin C, Sanli O, Amasyali AS, Tefik T, Seckin S,. Genetic variants of MnSOD and GPX1 and susceptibility to bladder cancer in a Turkish population. Med Oncol 2012; 29: 1928-1934
35. Eeles RA, Kote-Jarai Z, Al Olama AA, et al. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet 2009; 41: 1116-1121
36. Bostwick DG, Alexander EE, Singh R, et al. Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer. Cancer 2000; 89: 123-134
37. Mak JCW, Leung HCM, Ho SP, et al. Polymorphisms in manganese superoxide dismutase and catalase genes: functional study in Hong Kong Chinese asthma patients. Clin Exp Allergy 2006; 36: 440-447
38. Chistiakov DA, Zotova EV, Savost'anov KV, et al. The 262T>C promoter polymorphism of the catalase gene is associated with diabetic neuropathy in type 1 diabetic Russian patients. Diabetes Metab 2006; 32: 63-68
39. Zhou XF, Cui J, DeStefano AL, et al. Polymorphisms in the promoter region of catalase gene and essential hypertension. Dis Markers 2005; 21: 3-7
40. Kurosawa K, Shibata H, Hayashi N, Sato N, Kamada T, Tagawa K,. Kinetics of hydroperoxide degradation by NADP-glutathione system in mitochondria. J Biochem 1990; 108: 9-16
41. Bag A, Bag N,. Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk: a review. Cancer Epidemiol Biomarkers Prev 2008; 17: 3298-3305
42. Jackson JH,. Potential molecular mechanisms of oxidant-induced carcinogenesis. Environ Health Perspect 1994; 102 (Suppl.): 155-157
43. Nelson KK, Ranganathan AC, Mansouri J, et al. Elevated sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis. Clin Cancer Res 2003; 9: 424-432
44. Foster CB, Lehrnbecher T, Mol F, et al. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Invest 1998; 102: 2146-2155
45. Timofeeva M, Kropp S, Sauter W, et al. Genetic polymorphisms of MPO, GSTT1, GSTM1, GSTP1, EPHX1 and NQO1 as risk factors of early-onset lung cancer. Int J Cancer 2010; 127: 1547-1561
46. Wheatley-Price P, Asomaning K, Reid A, et al. Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma. Cancer 2008; 112: 1037-1042
47. Zhu H, Yang L, Zhou B, Yu R, Tang N, Wang B,. Myeloperoxidase G-463A polymorphism and the risk of gastric cancer: a case-control study. Carcinogenesis 2006; 27: 2491-2496
48. Henle ES, Linn S,. Formation, prevention, and repair of DNA damage by iron/hydrogen peroxide. J Biol Chem 1997; 272: 19095-19098
49. Whiteman M, Spencer JPE, Jenner A, Halliwell B,. Hypochlorous acid-induced DNA base modification?: Potentiation by nitrite?: Biomarkers of DNA damage by reactive oxygen species. Biochem Biophys Res Commun 1999; 576: 572-576